Atosiban Atosiban Acetate 90779-69-4
GMP Manafacturer
High Purity
Competitive Price
Short Delivery Time
Jixianglong has peptide drug production workshop which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Atosiban acetate, a synthetic peptide, prevents preterm birth in 24 - 33 - week pregnant women. It's highly effective, acting as an antagonist to block oxytocin and inhibit contractions rapidly and sustainably. Safety - wise, it has few systemic side effects, is fetal - friendly, and reduces neonatal complication risks. Backed by extensive clinical trials, it's recommended in guidelines and well - received by clinicians. Administered via IV infusion, it's easy to use and offers flexible dosing. With a reliable supply chain and strict quality control, we provide it at a competitive price, enhancing its accessibility for healthcare and patients.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.
Atosiban Acetate CAS No.: 90779-69-4
Sequence: Mpa-D-Tyr(ET)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2 (Disulfide bridge: Mpa1-Cys6)
Atosiban Acetate is an inhibitor of the hormones oxytocin and vasopressin. It is used to halt premature labor(>18 Years, GA: 24~33 Weeks). Atosiban is a synthetic peptide oxytocin antagonist.
Product Name | Atosiban Acetate |
CAS NO. | 90779-69-4 |
Appearance | White Powder |
Purity | 99% or customized |
Application | Drug peptides |
Usage | Atosiban is a desamino-oxytocin analogue, it is used to halt premature labor. |
Company Profile
Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View